Literature DB >> 9526555

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.

P W Smith1, S L Sollis, P D Howes, P C Cherry, I D Starkey, K N Cobley, H Weston, J Scicinski, A Merritt, A Whittington, P Wyatt, N Taylor, D Green, R Bethell, S Madar, R J Fenton, P J Morley, T Pateman, A Beresford.   

Abstract

4-Amino- and 4-guanidino-4H-pyran-6-carboxamides 4 and 5 related to zanamivir (GG167) are a new class of inhibitors of influenza virus sialidases. Structure--activity studies reveal that, in general, secondary amides are weak inhibitors of both influenza A and B viral sialidases. However, tertiary amides, which contain one or more small alkyl groups, show much greater inhibitory activity, particularly against the influenza A virus enzyme. The sialidase inhibitory activities of these compounds correlate well with their in vitro antiviral efficacy, and several of the most potent analogues displayed useful antiviral activity in vivo when evaluated in a mouse model of influenza A virus infection. Carboxamides which were highly active sialidase inhibitors in vitro also showed good antiviral activity in the mouse efficacy model of influenza A infection when administered intranasally but displayed modest activity when delivered by the intraperitoneal route.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9526555     DOI: 10.1021/jm970374b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

1.  Analysis of inhibitor binding in influenza virus neuraminidase.

Authors:  B J Smith; P M Colman; M Von Itzstein; B Danylec; J N Varghese
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

2.  Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.

Authors:  Wenwen Lian; Jiansong Fang; Chao Li; Xiaocong Pang; Ai-Lin Liu; Guan-Hua Du
Journal:  Mol Divers       Date:  2015-12-21       Impact factor: 2.943

3.  CONFIRM: connecting fragments found in receptor molecules.

Authors:  David C Thompson; R Aldrin Denny; Ramaswamy Nilakantan; Christine Humblet; Diane Joseph-McCarthy; Eric Feyfant
Journal:  J Comput Aided Mol Des       Date:  2008-07-09       Impact factor: 3.686

4.  Implications of protein conformations to modifying novel inhibitor Oseltamivir for 2009 H1N1 influenza A virus by simulation and docking studies.

Authors:  Sudha Singh; Anvita Gupta Malhotra; Mohit Jha; Khushhali Menaria Pandey
Journal:  Virusdisease       Date:  2018-09-01

5.  Consensus QSAR model for identifying novel H5N1 inhibitors.

Authors:  Nitin Sharma; Chun Wei Yap
Journal:  Mol Divers       Date:  2012-07-21       Impact factor: 2.943

6.  Structure-guided design of a novel class of benzyl-sulfonate inhibitors for influenza virus neuraminidase.

Authors:  Dimitris Platis; Brian J Smith; Trevor Huyton; Nikolaos E Labrou
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

7.  Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen.

Authors:  Simon J F Macdonald; Keith G Watson; Rachel Cameron; David K Chalmers; Derek A Demaine; Rob J Fenton; David Gower; J Nicole Hamblin; Stephanie Hamilton; Graham J Hart; Graham G A Inglis; Betty Jin; Haydn T Jones; Darryl B McConnell; Andy M Mason; Van Nguyen; Ian J Owens; Nigel Parry; Phillip A Reece; Stephen E Shanahan; Donna Smith; Wen-Yang Wu; Simon P Tucker
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

8.  Structure of an Escherichia coli N-acetyl-D-neuraminic acid lyase mutant, E192N, in complex with pyruvate at 1.45 angstrom resolution.

Authors:  Ivan Campeotto; Stephen B Carr; Chi H Trinh; Adam S Nelson; Alan Berry; Simon E V Phillips; Arwen R Pearson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-24

9.  Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus.

Authors:  Bo-Jian Zheng; Kwok-Wah Chan; Yong-Ping Lin; Guang-Yu Zhao; Chris Chan; Hao-Jie Zhang; Hong-Lin Chen; Samson S Y Wong; Susanna K P Lau; Patrick C Y Woo; Kwok-Hung Chan; Dong-Yan Jin; Kwok-Yung Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

Review 10.  Recent development in the synthesis of heterocycles by 2-naphthol-based multicomponent reactions.

Authors:  Ankita Chaudhary
Journal:  Mol Divers       Date:  2020-03-23       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.